JavaScript is disabled in your browser. Please enable JavaScript to view this website.

PLCH1

Function

The production of the second messenger molecules diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) is mediated by calcium-activated phosphatidylinositol-specific phospholipase C enzymes.

Involvement in disease

Holoprosencephaly 14

HPE14

An autosomal recessive form of holoprosencephaly, a structural anomaly of the brain in which the developing forebrain fails to correctly separate into right and left hemispheres. Holoprosencephaly is genetically heterogeneous and associated with several distinct facies and phenotypic variability. In its most severe form (alobar holoprosencephaly), the forebrain consists of a single ventricle, and midbrain structures may be malformed as well. In the most extreme cases, anophthalmia or cyclopia is evident along with a congenital absence of the mature nose. In milder forms (semilobar or lobar holoprosencephaly), rudimentary midline structures are present. The less severe form features facial dysmorphism characterized by ocular hypertelorism, defects of the upper lip and/or nose, and absence of the olfactory nerves or corpus callosum.

None

The disease is caused by variants affecting the gene represented in this entry.

Tissue Specificity

Expressed in brain and to a lower extent in lung. In brain, it is found in cerebrum, cerebellum and spinal cord. In embryo expressed in the notochord, developing spinal cord (in a ventral to dorsal gradient), dorsal root ganglia, cerebellum and dermatomyosome.

Cellular localization

Alternative names

KIAA1069, PLCL3, PLCH1, Phosphoinositide phospholipase C-eta-1, Phospholipase C-eta-1, Phospholipase C-like protein 3, PLC-eta-1, PLC-L3

swissprot:Q4KWH8 entrezGene:23007 omim:612835